- Home
- MYGN vs MLR Comparison
MYGN vs MLR Comparison
Compare MYGN & MLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- MLR
- Stock Information
- Founded
- MYGN 1991
- MLR 1990
- Country
- MYGN United States
- MLR United States
- Employees
- MYGN N/A
- MLR N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MLR Construction/Ag Equipment/Trucks
- Sector
- MYGN Health Care
- MLR Consumer Discretionary
- Exchange
- MYGN Nasdaq
- MLR Nasdaq
- Market Cap
- MYGN 423.1M
- MLR 492.7M
- IPO Year
- MYGN 1995
- MLR 1994
- Fundamental
- Price
- MYGN $7.64
- MLR $40.41
- Analyst Decision
- MYGN Hold
- MLR Strong Buy
- Analyst Count
- MYGN 13
- MLR 1
- Target Price
- MYGN $13.50
- MLR $64.00
- AVG Volume (30 Days)
- MYGN 1.4M
- MLR 114.2K
- Earning Date
- MYGN 11-06-2025
- MLR 11-11-2025
- Dividend Yield
- MYGN N/A
- MLR 1.95%
- EPS Growth
- MYGN N/A
- MLR N/A
- EPS
- MYGN N/A
- MLR 3.64
- Revenue
- MYGN $832,900,000.00
- MLR $975,860,000.00
- Revenue This Year
- MYGN $0.17
- MLR N/A
- Revenue Next Year
- MYGN $6.19
- MLR $9.23
- P/E Ratio
- MYGN N/A
- MLR $11.30
- Revenue Growth
- MYGN 3.83
- MLR N/A
- 52 Week Low
- MYGN $3.76
- MLR $33.81
- 52 Week High
- MYGN $29.30
- MLR $78.25
- Technical
- Relative Strength Index (RSI)
- MYGN 75.45
- MLR 42.05
- Support Level
- MYGN $6.73
- MLR $39.45
- Resistance Level
- MYGN $7.05
- MLR $41.17
- Average True Range (ATR)
- MYGN 0.38
- MLR 1.12
- MACD
- MYGN 0.10
- MLR -0.22
- Stochastic Oscillator
- MYGN 94.31
- MLR 17.02
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About MLR Miller Industries Inc.
Miller Industries Inc is engaged in the manufacturing of vehicle towing and recovery equipment. The company produces wreckers, car carriers, and trailer bodies under the Century, Vulcan, Challenger, Holmes, Champion, Chevron, Eagle, Titan, Jige, and Boniface brands. The products are sold in North America, Canada, and Mexico through independent distributors.